非典型性指数作为孕早期染色体异常联合筛查的附加指标
该研究基于丹麦2008年1月至2018年12月的中丹麦地区数据,对145955例单胎妊娠计算基于孕早期联合筛查标志物的非典型性指数,并加入孕中期估计胎儿体重。结果显示筛查阴性且非典型性指数极低的孕妇染色体异常风险显著降低,而非典型性指数高的孕妇风险显著增加。
要点
- 非典型性指数可量化孕早期筛查标志物的不寻常程度,0%代表最典型,100%代表最不典型。
- 筛查阴性且孕早期非典型性指数<80%者染色体异常风险为0.28%,显著低于总体风险。
- 非典型性指数≥99%者染色体异常风险显著升高,孕早期为4.44%,加入孕中期估计胎儿体重后为4.16%。
核心结论
- 作为联合筛查的附加指标,非典型性指数可识别测量特征典型的孕妇,可能提供 reassurance;而非典型特征可能需要专科转诊和进一步检查。
- 联合筛查低风险但NT、PAPP-A和β-hCG分布高度不典型的妊娠,染色体异常风险显著增加。
研究设计与样本
- 基于丹麦胎儿医学数据库的回顾性研究,纳入2008年1月至2018年12月在中丹麦地区接受孕早期联合筛查的所有单胎妊娠,共145955例,其中9824例(6.7%)接受了遗传学检查。
主要发现
- 所有接受联合筛查的妊娠中,胎儿染色体异常总体患病率为1/122(0.82%,95%CI 0.77-0.87%);筛查阴性妊娠中为0.41%(95%CI 0.38-0.44%)。
- 筛查阴性且孕早期非典型性指数<80%者染色体异常风险为0.28%,显著低于总体风险。
- 孕早期非典型性指数[80-90%)组风险为0.49%,[90-99%)组为1.52%,≥99%组为4.44%,后两组风险显著增加。
- 孕中期非典型性指数[90-99%)组风险为0.76%,≥99%组为4.16%。
临床怎么用
- 作者认为非典型性指数可作为联合筛查的附加指标,用于识别测量特征典型的孕妇以提供 reassurance,而非典型特征可能需要专科转诊和进一步检查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compute a set of atypicality indices based on combined first-trimester screening (cFTS) markers and second-trimester estimated fetal weight (EFW), and to demonstrate their potential in identifying pregnancies at reduced or increased risk of chromosomal aberrations following a low-risk cFTS result. METHODS: The atypicality index quantifies the unusualness of an individual set of measurements relative to a reference distribution and can be computed from any variables or measurements available. A score of 0% on the atypicality index represents the most typical profiles, while a score of 100% indicates the highest level of atypicality. From the Danish Fetal Medicine Database, we retrieved data on all pregnant women seen for cFTS in the Central Denmark Region between January 2008 and December 2018. All pregnancies with a cytogenetic or molecular analysis obtained prenatally, postnatally or following pregnancy loss or termination were identified. A first-trimester atypicality index (AcFTS) was computed based on nuchal translucency (NT) thickness, maternal serum free β-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein-A (PAPP-A). Furthermore, a second-trimester index (AcFTS + EFW) was computed from cFTS markers and EFW from a routine second-trimester anomaly scan. All pregnancies were stratified into subgroups based on their atypicality levels and their cFTS risk estimates. The risk of chromosomal aberrations in each subgroup was then compared with the overall prevalence, and a graphical presentation of the multivariate measurement profiles was developed. RESULTS: We retrieved data on 145 955 singleton pregnancies, of which 9824 (6.7%) were genetically examined. Overall, 1 in 122 (0.82% (95% CI, 0.77-0.87%)) of all pregnancies seen for cFTS were affected by a fetal chromosomal aberration, and in screen-negative pregnancies (cFTS trisomy 21 risk < 1 in 100 and/or trisomy 18/13 risk < 1 in 50), 0.41% (95% CI, 0.38-0.44%) were affected. In screen-negative pregnancies with a typical first-trimester profile (AcFTS < 80%), the risk of chromosomal aberrations was significantly reduced (0.28%) compared with the overall risk. The risk of chromosomal aberrations increased with higher atypicality index to 0.49% (AcFTS [80-90%)), 1.52% (AcFTS [90-99%)) and 4.44% (AcFTS ≥ 99%) and was significantly increased in the two most atypical subgroups. The same applied for the second-trimester atypicality index, with risks of chromosomal aberrations of 0.76% and 4.16% in the two most atypical subgroups (AcFTS + EFW [90-99%) and AcFTS + EFW ≥ 99%, respectively). CONCLUSIONS: As an add-on to cFTS, the atypicality index identifies women with typical measurement profiles, which may provide reassurance, whereas atypical profiles may warrant specialist referral and further investigation. In pregnancies identified as low risk on cFTS but with a highly atypical distribution of NT, PAPP-A and β-hCG, the risk of a chromosomal aberration is substantially increased. The atypicality index optimizes the interpretation of pre-existing prenatal screening profiles and is not limited to cFTS markers or EFW. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Gadsbøll K, Vogel I, Pedersen LH, et al. Atypicality index as an add-on to combined first-trimester screening for chromosomal aberrations. Ultrasound Obstet Gynecol. 2024. PMID: 38112514. doi:10.1002/uog.27562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。